Have COVID-19 pandemic restrictions impacted the functioning of the hematology clinic? [PDF]
, 2021 Amaç: Çalışmamızın amacı, kısıtlamaların uygulandığı COVID-19 pandemi sürecinde hematoloji klinik işleyişinin değerlendirilmesidir. Hastalar ve Yöntem: Pandeminin ilk döneminde sokağa çıkma kısıtlamalarının uygulandığı 13.03.2020-15.05.2020 ile bu tarih ...
Demircioğlu, Sinan +6 more
core +1 more source
Hematology, Transfusion and Cell Therapy, 2023 Objective: Acute leukemia is the most common pediatric hematological malignancy. Blood stream infections (BSI) are severe complications in these patients during chemotherapy.
F.Burçin Kurtipek +6 more
doaj +1 more source
Lenalidomide-based treatment results in patients with relapsed/refractory lymphoma (excluding mantle cell lymphoma): A multi-centre experience [PDF]
, 2021 Amaç: Lenfomalar, çoğunlukla B hücre kökenli heterojen bir hastalık grubunu temsil eder. Lenalidomid, kemo-immünoterapötik ajanlara talidomidin yapısal bir analoğu olarak dahil edilmiştir.
Doğu, Mehmet Hilmi +4 more
core +2 more sources
Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome
Ankara Üniversitesi Tıp Fakültesi Mecmuası, 2020 Objectives:Myelodysplastic syndrome (MDS) is a clonal disease that progresses with cytopenias and has leukemia transformation. Allogeneic Stem Cell Transplantation (ASCT) is a curative treatment in MDS patients.
Pınar Ataca Atilla +10 more
doaj +1 more source
Single Centre Experience: Bening and Malign Hematological Patients with COVID-19 [PDF]
, 2022 Introduction Coronavirus disease 2019 (COVID-19) were declared as pandemic by World Health Organization. With this study, we aimed to define our patients who were followed up with malign or benign hematological diagnoses and diagnosed with COVID-19 ...
Buğra Sağlam +8 more
core +2 more sources
Turkish Journal of Internal Medicine, 2023 Background Hairy cell leukemia (HCL) is an uncommon neoplasm representing approximately 2% leukemias ...
Tuba Ersal +9 more
doaj +1 more source
Our Treatment Approach to Hairy Cell Leukemia
Ankara Üniversitesi Tıp Fakültesi Mecmuası, 2020 Objectives:Hairy cell leukemia (HCL) is a rare chronic lymphoid malignancy which develops from mature B cells. The frequency is 2% of all leukemias and diagnosed mostly in middle ages. Patients respond to treatment with purine analogues.
Pınar Ataca Atilla +11 more
doaj +1 more source
Risk factors and outcomes for carbapenem-resistant klebsiella pneumoniae in hematological patients
Turkish Journal of Internal Medicine, 2023 Background Prolonged hospitalization, prolonged neutropenia, and immunosuppressive treatments increase bloodstream infections in hematological patients.
Selda Kahraman +2 more
doaj +1 more source
Akut Myeloid Lösemi (AML) tanılı erişkin hastalarda Nükleofosmin (NPM1) ve FMS Like Tirozin Kinaz (FLT3) mutasyonun insidansı ve sağ kalıma etkisi; Tek merkez deneyimi [PDF]
, 2022 Introduction: Acute Myeloid Leukaemia (AML) is a disease characterized by bone marrow failure due to increased proliferation resulting from the protection of myeloid precursor cells from differentiation and apoptosis control in the bone marrow ...
Karakuş, Abdullah +3 more
core +1 more source
Primary Mediastinal Large B-Cell Lymphoma: Case Report
Turkish Journal of Internal Medicine, 2022 Primary mediastinal large B-cell lymphoma is a rare tumour. Patients present with dyspnea, cough, dysphagia and superior vena cava syndrome. Thus, most patients are diagnosed early in stages 1-2.
Ömer Candar +4 more
doaj +1 more source